Platelet inhibitor agents in cardiovascular disease: an update.

[1]  V. Fidler,et al.  IMPROVED PRIMARY RENAL ALLOGRAFT SURVIVAL ON CYCLOSPORIN LIMITED TO WOMEN WITH PREVIOUS PREGNANCIES , 1989, The Lancet.

[2]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[3]  A. Pichard,et al.  Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. , 1989, The American journal of cardiology.

[4]  V. Fuster,et al.  Aspirin in the prevention of coronary disease. , 1989, The New England journal of medicine.

[5]  V. Hachinski,et al.  THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.

[6]  B. Waller.  "Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters"--the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment. , 1989, Journal of the American College of Cardiology.

[7]  S. Ellis,et al.  Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. , 1989, American heart journal.

[8]  J. Hopper,et al.  Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. , 1989, Journal of the American College of Cardiology.

[9]  W J Penny,et al.  Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. , 1989, Circulation.

[10]  D. Doyle,et al.  Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. , 1989, The New England journal of medicine.

[11]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[12]  R. Mesa-Tejada,et al.  Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.

[13]  A. Bini.  Identification and distribution of fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis , 1989 .

[14]  M. Debakey,et al.  The St. Jude valve prosthesis: analysis of the clinical results in 815 implants and the need for systemic anticoagulation. , 1989, Journal of the American College of Cardiology.

[15]  B. Rabinowitz,et al.  [Aspirin in coronary heart disease]. , 1989, Harefuah.

[16]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[17]  P. Théroux,et al.  Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.

[18]  J. Popma,et al.  Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. , 1988, The New England journal of medicine.

[19]  L. Campeau,et al.  Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. , 1988, Circulation.

[20]  V. Fuster,et al.  Importance of adequate heparin dosage in arterial angioplasty in a porcine model. , 1988, Circulation.

[21]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[22]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[23]  L Schwartz,et al.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.

[24]  L. Hillis,et al.  Restenosis after successful coronary angioplasty. Pathophysiology and prevention. , 1988, The New England journal of medicine.

[25]  V. Fuster,et al.  Insights into the pathogenesis of acute ischemic syndromes. , 1988, Circulation.

[26]  Thomas E. Moritz,et al.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. , 1988, Circulation.

[27]  K. Kent.  Restenosis after percutaneous transluminal coronary angioplasty. , 1988, The American journal of cardiology.

[28]  S. Hanson,et al.  Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Rahimtoola,et al.  Impaired fibrinolysis in coronary artery disease. , 1988, American heart journal.

[30]  K. Mullane,et al.  Thromboxane Synthetase Inhibitors Reduce Infarct Size by a Platelet‐Dependent, Aspirin‐Sensitive Mechanism , 1988, Circulation research.

[31]  H. Gold,et al.  Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. , 1988, Circulation.

[32]  R Gorlin,et al.  Angiographic demonstration of a common link between unstable angina pectoris and non-Q-wave acute myocardial infarction. , 1988, The American journal of cardiology.

[33]  United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results , 1988, British medical journal.

[34]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[35]  K. McPherson,et al.  Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.

[36]  S. Hanson,et al.  Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. , 1988, The Journal of clinical investigation.

[37]  Symposium on Myocardial Reperfusion 1988: practical considerations. , 1988, Journal of the American College of Cardiology.

[38]  P. Rigo,et al.  Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. , 1987, The Journal of thoracic and cardiovascular surgery.

[39]  E. Sowton,et al.  The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study. , 1987, British heart journal.

[40]  L. Edmunds,et al.  Thrombotic and bleeding complications of prosthetic heart valves. , 1987, The Annals of thoracic surgery.

[41]  V. Fuster,et al.  Mechanism of arterial thrombosis platelet thrombus deposition in areas of stenosis , 1987 .

[42]  J. Mimuro,et al.  Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. , 1987, Blood.

[43]  M. Bourassa,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. , 1987, The American journal of cardiology.

[44]  J. Douglas,et al.  Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. , 1987, The American journal of cardiology.

[45]  Lynne H. Taylor,et al.  Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. , 1987, Circulation.

[46]  H. Eichler,et al.  Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. , 1987, Circulation.

[47]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[48]  L. Wilkins.  High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. , 1987, Stroke.

[49]  C. Fisher,et al.  Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. , 1987, The Journal of laboratory and clinical medicine.

[50]  J. Hawiger.  Formation and regulation of platelet and fibrin hemostatic plug. , 1987, Human pathology.

[51]  L. Brass,et al.  Induction of the fibrinogen receptor on human platelets by intracellular mediators. , 1987, The Journal of biological chemistry.

[52]  J. Oates,et al.  Drug therapy. Dipyrimadole , 1987 .

[53]  C. von Schacky.  Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy. , 1987, Annals of internal medicine.

[54]  V. Fuster,et al.  Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. , 1987, Circulation.

[55]  G. Clagett,et al.  Antithrombotic therapy in peripheral vascular disease. , 1989, Chest.

[56]  V. Fuster,et al.  Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. , 1986, Journal of the American College of Cardiology.

[57]  V. Fuster,et al.  Pharmacology of platelet inhibitors. , 1986, Journal of the American College of Cardiology.

[58]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[59]  L Morgenstern,et al.  Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.

[60]  R. Rosenberg,et al.  Heparin inhibition of smooth muscle cell proliferation: A cellular site of action , 1986, Journal of cellular physiology.

[61]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[62]  T. P. Judge,et al.  Coronary arteriographic findings soon after non-Q-wave myocardial infarction. , 1986, The New England journal of medicine.

[63]  B. Coller.  Activation affects access to the platelet receptor for adhesive glycoproteins , 1986, The Journal of cell biology.

[64]  M. Gheorghiade,et al.  The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. , 1986, Circulation.

[65]  W. S. Fields,et al.  Controlled trial of aspirin in cerebral ischemia , 1986, Neurology.

[66]  R. Alexander,et al.  Vasoconstriction: a new activity for platelet-derived growth factor. , 1986, Science.

[67]  J. White,et al.  Organization of the actin cytoskeleton of resting and activated platelets in suspension. , 1986, The American journal of pathology.

[68]  B Meier,et al.  Restenosis after successful coronary angioplasty in patients with single-vessel disease. , 1986, Circulation.

[69]  E L Bolson,et al.  Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. , 1986, Circulation.

[70]  D. Graham,et al.  Aspirin and the stomach. , 1986, Annals of internal medicine.

[71]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[72]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[73]  V. Fuster,et al.  Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. , 1986, Circulation.

[74]  V. Fuster,et al.  Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis. , 1986, Progress in hemostasis and thrombosis.

[75]  Block Pc.  Percutaneous transluminal coronary angioplasty: role in the treatment of coronary artery disease. , 1985 .

[76]  P. Halushka,et al.  Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. , 1985, Circulation.

[77]  G. FitzGerald,et al.  The biochemical pharmacology of thromboxane synthase inhibition in man. , 1985, Circulation.

[78]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[79]  A. Tajik,et al.  Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. , 1985, The New England journal of medicine.

[80]  C. Mok,et al.  Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.

[81]  E. Peerschke.  The platelet fibrinogen receptor. , 1985, Seminars in hematology.

[82]  Ivar Heuch,et al.  Fish consumption and mortality from coronary heart disease. , 1985, The New England journal of medicine.

[83]  S. Rajah,et al.  Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial. , 1985, The Journal of thoracic and cardiovascular surgery.

[84]  B. G. Brown,et al.  Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. , 1985, Circulation.

[85]  G. Guiraudon,et al.  Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. , 1985, Circulation.

[86]  V. Fuster,et al.  Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. , 1985, Circulation research.

[87]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[88]  L. Wilkins.  Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985 .

[89]  M. Bourassa,et al.  Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. , 1985, American heart journal.

[90]  M. Griffith,et al.  The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation. , 1985, Blood.

[91]  S. Hanson,et al.  Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. , 1985, The Journal of clinical investigation.

[92]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[93]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[94]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[95]  G. Deichsel,et al.  DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE A Prospective Double-Blind Arteriographically Controlled Trial , 1985, The Lancet.

[96]  J. Pepper,et al.  Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. , 1985, British heart journal.

[97]  V. V. van Hinsbergh,et al.  Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. , 1985, Blood.

[98]  A. Einstein,et al.  Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985, Stroke.

[99]  P. Block.  Percutaneous transluminal coronary angioplasty: role in the treatment of coronary artery disease. , 1985, Circulation.

[100]  S L Winters,et al.  Angiographic morphology and the pathogenesis of unstable angina pectoris. , 1985, Journal of the American College of Cardiology.

[101]  H. Aldridge,et al.  The use of dextran-40 during percutaneous transluminal coronary angioplasty: a report of three cases of anaphylactoid reactions--one near fatal. , 1985, Catheterization and cardiovascular diagnosis.

[102]  P. Gresele,et al.  Thromboxane Synthase Inhibition Combined with Thromboxane Receptor Blockade: A Step Forward in Antithrombotic Strategy? , 1984, Thrombosis and Haemostasis.

[103]  Weksler Bb.  Prostaglandins and vascular function. , 1984 .

[104]  T. Bateman,et al.  The St. Jude Medical bileaflet valve prosthesis. A 5 year experience. , 1984, The Journal of thoracic and cardiovascular surgery.

[105]  B. Weksler.  Prostaglandins and vascular function , 1984, Circulation.

[106]  D. Loskutoff,et al.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. , 1984, The Journal of clinical investigation.

[107]  D. Holmes,et al.  Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty. , 1984, The American journal of cardiology.

[108]  P. Weber,et al.  IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY) Effects on Platelet Aggregation and Thromboxane Formation , 1984, The Lancet.

[109]  J. Hirsh,et al.  The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor , 1984, British journal of haematology.

[110]  E. Myhre,et al.  Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease. , 1984, The American journal of cardiology.

[111]  J. Douglas,et al.  Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. , 1984, Circulation.

[112]  V. Fuster,et al.  Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin. , 1984, Circulation.

[113]  V. Fuster,et al.  Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. , 1984, The New England journal of medicine.

[114]  J. Oliver,et al.  Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. , 1984, The Annals of thoracic surgery.

[115]  B. Bulkley,et al.  Nontransmural versus transmural myocardial infarction. A morphologic study. , 1983, The American journal of medicine.

[116]  S. Khuri,et al.  The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. , 1983, Circulation.

[117]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[118]  M. Hunkapiller,et al.  Human platelet-derived growth factor (PDGF): amino-terminal amino acid sequence. , 1983, Science.

[119]  V. Fuster,et al.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.

[120]  K Amplatz,et al.  Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. , 1983, The American journal of cardiology.

[121]  J. Cairns,et al.  Effects of dazoxiben on exercise performance in chronic stable angina. , 1983, British journal of clinical pharmacology.

[122]  P. Sørensen,et al.  Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. , 1983, Stroke.

[123]  T. Oshima,et al.  Recanalization of obstructed coronary artery by intracoronary administration of prostacyclin in patients with acute myocardial infarction. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

[124]  B. Kirchhof,et al.  Determination of prothrombin by a micro-coagulation method. , 1983, Haemostasis.

[125]  R. Roncucci,et al.  Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications. , 1983, Haemostasis.

[126]  P. Touboul,et al.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.

[127]  M. Dunn,et al.  Prostacyclin substitution for heparin in long-term hemodialysis. , 1982, The American journal of medicine.

[128]  V. Fuster,et al.  Systemic thromboembolism in mitral and aortic Starr-Edwards prostheses: a 10-19 year follow-up. , 1982, Circulation.

[129]  D C Levin,et al.  Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.

[130]  V. Fuster,et al.  A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. , 1982, The New England journal of medicine.

[131]  T. Katsumura,et al.  Therapeutic Effect of Ticlopidine, a New Inhibitor of Platelet Aggregation, on Chronic Arterial Occlusive Diseases, a Double-blind Study versus Placebo , 1982, Angiology.

[132]  O. Munck,et al.  ACETYLSALICYLIC ACID IN THE PREVENTION OF STROKE IN PATIENTS WITH REVERSIBLE ISCHEMIC ATTACKS: , 1982 .

[133]  T. Ryan,et al.  Acute Effects of Transluminal Angioplasty in Three Experimental Models of Atherosclerosis , 1982, Arteriosclerosis.

[134]  H. Baur,et al.  Effects of sulfinpyrazone on early graft closure after myocardial revascularization. , 1982, The American journal of cardiology.

[135]  S. Gates,et al.  The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. , 1982, The Journal of thoracic and cardiovascular surgery.

[136]  A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. , 1982, The New England journal of medicine.

[137]  E. J. Brown,et al.  Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. , 1981, The New England journal of medicine.

[138]  J. Caen,et al.  The In Vitro Effect of Ticlopidine on Fibrinogen and Factor VIII Binding to Human Platelets , 1981, Thrombosis and Haemostasis.

[139]  J. Fallon,et al.  Morphology after transluminal angioplasty in human beings. , 1981, The New England journal of medicine.

[140]  R. Heinrikson,et al.  Platelet factor 4 is chemotactic for neutrophils and monocytes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[141]  A. Telford,et al.  TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROME , 1981, The Lancet.

[142]  R. Bianco,et al.  Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin. , 1981, The American journal of cardiology.

[143]  J. Mayer,et al.  Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts. , 1981, The Annals of thoracic surgery.

[144]  M. Sobel,et al.  Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[145]  R. Pierce,et al.  The affinity of platelets for the subendothelium. , 1981, The American surgeon.

[146]  J. Stamler.  Aspirin in coronary heart disease , 1980 .

[147]  K. Breddin,et al.  The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. , 1980, Circulation.

[148]  Persantine and Aspirin in Coronary Heart Disease , 1980 .

[149]  Lippincott Williams Wilkins,et al.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.

[150]  U. Ryan,et al.  Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. , 1980, The Journal of clinical investigation.

[151]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[152]  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.

[153]  R. Rosenberg,et al.  Effect of heparin and heparin fractions on platelet aggregation. , 1980, The Journal of clinical investigation.

[154]  P. Elwood,et al.  ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.

[155]  V. Fuster,et al.  Noninvasive Radioisotopic Technique for Detection of Platelet Deposition in Coronary Artery Bypass Grafts in Dogs and Its Reduction with Platelet Inhibitors , 1979, Circulation.

[156]  S. Rahimtoola,et al.  Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. , 1979, The New England journal of medicine.

[157]  P. Steele,et al.  Platelet Suppressant Therapy in Patients with Prosthetic Cardiac Valves: Relationship of Clinical Effectiveness to Alteration of Platelet Survival Time , 1979, Circulation.

[158]  P. Majerus,et al.  Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. , 1979, The New England journal of medicine.

[159]  S Moncada,et al.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.

[160]  W. S. Fields,et al.  Controlled Trial of Aspirin in Cerebral Ischemia. Part II: Surgical Group , 1978, Stroke.

[161]  S. Moncada,et al.  DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN , 1978, The Lancet.

[162]  Eade Oe,et al.  Coeliac lung disease. , 1978, Lancet.

[163]  M. Åberg,et al.  Effect of dextran 70 on factor VIII and platelet function in von Willebrand's disease. , 1978, Thrombosis research.

[164]  Harker La.  Platelet survival time: its measurement and use. , 1978 .

[165]  J. Fox,et al.  Cyclic Nucleotides in Platelet Function , 1977, Thrombosis and Haemostasis.

[166]  A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.

[167]  L. Harker.  Platelet survival time: its measurement and use. , 1978, Progress in hemostasis and thrombosis.

[168]  G. Lawrie,et al.  Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. , 1977, The American journal of cardiology.

[169]  T C Chalmers,et al.  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. , 1977, The New England journal of medicine.

[170]  T. Tschopp.  Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: an assessment of platelet adhesion and deposited platelet mass by morphometry and 51Cr-labeling. , 1977, Thrombosis research.

[171]  T. Kasahara.  [Clinical effect of dipyridamole ingestion after prosthetic heart valve replacement--especially on the blood coagulation system (author's transl)]. , 1977, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[172]  E. Myhre,et al.  Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. , 1977, American heart journal.

[173]  R. Hardy,et al.  Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.

[174]  Karnovsky Mj,et al.  Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. , 1977 .

[175]  A. Clowes,et al.  Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.

[176]  G. Hutchins,et al.  Accelerated “Atherosclerosis” A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts: A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts , 1977, Circulation.

[177]  M. Karnovsky,et al.  Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[178]  H. Barnett,et al.  Cerebral ischemic events associated with prolapsing mitral valve. , 1976, Archives of neurology.

[179]  R. Altman,et al.  Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. , 1976, The Journal of thoracic and cardiovascular surgery.

[180]  P. Majerus,et al.  The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. , 1975, The Journal of clinical investigation.

[181]  R. Frye,et al.  Pathologic changes in aortocoronary saphenous vein grafts. , 1974, The American journal of cardiology.

[182]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[183]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[184]  W. Hoyt,et al.  Letter: Suprastriate hemianopia. , 1974, Lancet.

[185]  P C Elwood,et al.  A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.

[186]  J. Baak,et al.  Letter: The thymus and sudden unexplained infant death. , 1974, Lancet.

[187]  P. Steele,et al.  Platelet survival in patients with substitute heart valves. , 1974, The New England journal of medicine.

[188]  J. Hirsh,et al.  Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. , 1974, The New England journal of medicine.

[189]  Z. J. Lipowski.  Letter: Psychosomatic medicine. , 1974, Lancet.

[190]  R. Ebert,et al.  Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial , 1973 .

[191]  A Drapkin,et al.  Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. , 1972, JAMA.

[192]  W. Roberts,et al.  The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. , 1972, The American journal of medicine.

[193]  R. Gorlin,et al.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement. , 1971, The New England journal of medicine.

[194]  L. Harker,et al.  Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. , 1970, The New England journal of medicine.

[195]  R. Ebert.  Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. , 1969, JAMA.

[196]  J. A. Brown,et al.  Glomerular Filtration Rate , 1967 .

[197]  H. Weiss,et al.  The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies. , 1967, The Journal of laboratory and clinical medicine.

[198]  E. Rice-wray.  AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL. , 1964, British medical journal.

[199]  An Assessment of Long-term Anticoagulant Administration after Cardiac Infarction , 1959, British medical journal.